Park Medi World Limited Schedules Board Meeting on January 28, 2026 for Q3FY26 Financial Results

1 min read Updated on 22 Jan 2026, 04:16 PM

Reviewed by

Naman SScanX News Team

Overview

Park Medi World Limited has scheduled a board meeting for January 28, 2026, to consider and approve Q3FY26 unaudited financial results for the quarter and nine months ended December 31, 2025. The company has notified BSE and NSE in compliance with SEBI Regulation 29. Trading window restrictions are in effect from December 31, 2025, until 48 hours after results publication, as per the company's insider trading prevention code.

*this image is generated using AI for illustrative purposes only.

Park Medi World Limited has announced a board meeting scheduled for January 28, 2026, to review and approve its unaudited financial results for the third quarter of fiscal year 2026. The company formally notified both major stock exchanges about this important corporate development through official communications dated January 22, 2026.

Board Meeting Details

The meeting agenda focuses on considering and approving both standalone and consolidated unaudited financial results for specific reporting periods. The company has structured this review to cover comprehensive financial performance across different operational segments.

Meeting Parameter:	Details
Date:	January 28, 2026
Purpose:	Q3FY26 unaudited financial results
Reporting Period:	Quarter ended December 31, 2025
Extended Period:	Nine months ended December 31, 2025
Result Type:	Standalone and consolidated

Regulatory Compliance

Park Medi World Limited has fulfilled its disclosure obligations under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company submitted formal intimations to both BSE Limited at P.J. Tower, Dalal Street, Fort, Mumbai, and National Stock Exchange of India Limited at Exchange Plaza, Bandra-Kurla Complex, Mumbai.

Trading Window Restrictions

In accordance with the company's Code of Conduct for Prevention of Insider Trading, specific trading restrictions have been implemented. The trading window for Park Medi World Limited securities will remain closed from Wednesday, December 31, 2025, continuing until 48 hours after the financial results are made public.

Trading Window Details:	Information
Closure Start:	December 31, 2025
Closure End:	48 hours post-results publication
Applicable Securities:	All company securities
Compliance Framework:	Insider Trading Prevention Code

Corporate Communication

The official communication was signed by Abhishek Kapoor, serving as Company Secretary & Compliance Officer. The digital signature was executed on January 22, 2026, at 15:27:24 +05'30', ensuring proper authentication and regulatory compliance for this material disclosure.

Expansion Overview

The healthcare provider has set a target of achieving more than 5,000 beds across its network by FY2028. This expansion represents part of the company's broader national growth initiative.

Strategic Direction

Park Medi World's expansion plans focus on national market penetration, though specific details regarding target locations, investment requirements, or implementation phases were not provided in the available information.

The company's growth strategy appears centered on significantly scaling its healthcare infrastructure capacity over the coming years to meet increasing healthcare demands across the country.